Abstract:Emerging and re-emerging viral pandemics have emerged as a major public health concern. Highly pathogenic coronaviruses, which cause severe respiratory disease, threaten human health and socioeconomic development. Great efforts are being devoted to the development of safe and efficacious therapeutic agents and preventive vaccines to combat them. Nevertheless, the highly mutated virus poses a challenge to drug development and vaccine efficacy, and the use of common immunomodulatory agents lacks specificity. Benefiting from the burgeoning intersection of biological engineering and biotechnology, membrane-derived vesicles have shown superior potential as therapeutics due to their biocompatibility, design flexibility, remarkable bionics, and inherent interaction with phagocytes. The interactions between membrane-derived vesicles, viruses, and the immune system have emerged as a new and promising topic. This review provides insight into considerations for developing innovative antiviral strategies and vaccines against SARS-CoV-2. First, membrane-derived vesicles may provide potential biomimetic decoys with a high affinity for viruses to block virus-receptor interactions for early interruption of infection. Second, membrane-derived vesicles could help achieve a balanced interplay between the virus and the host's innate immunity. Finally, membrane-derived vesicles have revealed numerous possibilities for their employment as vaccines. Membrane-derived vesicles have attracted a considerable amount of interest due to their biocompatibility, design flexibility, remarkable bionics, and inherent interaction with phagocytes. They may provide potential therapeutics to protect individuals from SARS-CoV-2 infection, including blocking of viral entry as biomimetic decoys, achieving a balanced immunoregulation, and improving vaccine efficacy. image

Author Response for "from Virus to Immune System: Harnessing Membrane‐derived Vesicles to Fight COVID‐19 by Interacting with Biological Molecules"